These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31074949)

  • 1. Association of Autoantibody Quantification With Systemic Lupus Erythematosus Disease Activity: Comment on the Article by Kim et al.
    Tang X; Ning M; Zhu Y; Zhu Y; Xu Y; Wu S; Feng X
    Arthritis Rheumatol; 2019 Sep; 71(9):1588-1590. PubMed ID: 31074949
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement activation in patients with systemic lupus erythematosus without nephritis.
    Mollnes TE; Haga HJ; Brun JG; Nielsen EW; Sjöholm A; Sturfeldt G; Mårtensson U; Bergh K; Rekvig OP
    Rheumatology (Oxford); 1999 Oct; 38(10):933-40. PubMed ID: 10534542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Combination of Complement Activation Products With Autoantibodies Predicts Transition of Probable Lupus to Systemic Lupus Erythematosus: Comment on the Article by Lambers et al.
    Vezza Alexander R; Weinstein A
    Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1827. PubMed ID: 32976689
    [No Abstract]   [Full Text] [Related]  

  • 4. The expression of C3b receptors in the differentiation of discoid lupus erythematosus and systemic lupus erythematosus.
    Tausk F; Harpster E; Gigli I
    Arthritis Rheum; 1990 Jun; 33(6):888-92. PubMed ID: 2141982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.
    Hristova MH; Stoyanova VS
    Lupus; 2017 Dec; 26(14):1550-1555. PubMed ID: 29092674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
    Wilson JG; Wong WW; Schur PH; Fearon DT
    N Engl J Med; 1982 Oct; 307(16):981-6. PubMed ID: 7110302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
    Yoshida K; Yukiyama Y; Miyamoto T
    J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [RESEARCH ON THE ANTIRENAL AUTOANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS].
    MANGANOTTI G; CAPITANI G; GADDONI G
    Arch Ital Dermatol Venereol Sessuol; 1963 Oct; 32():100-8. PubMed ID: 14104035
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply.
    Kim AHJ; Strand V; Atkinson JP
    Arthritis Rheumatol; 2019 Sep; 71(9):1590-1592. PubMed ID: 31074940
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-Apolipoprotein A-I in Systemic Lupus Erythematosus: Comment on the Article by Kim et al.
    Vuilleumier N
    Arthritis Rheumatol; 2020 Jul; 72(7):1233-1234. PubMed ID: 32103622
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement and systemic lupus erythematosus.
    Karp DR
    Curr Opin Rheumatol; 2005 Sep; 17(5):538-42. PubMed ID: 16093830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus.
    Negoro N; Okamura M; Takeda T; Koda S; Amatsu K; Inoue T; Curd JG; Kanayama Y
    Arthritis Rheum; 1989 Oct; 32(10):1233-42. PubMed ID: 2803326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement. Findings in systemic lupus erythematosus.
    Durand CG; Burge JJ
    J Immunol Methods; 1984 Oct; 73(1):57-66. PubMed ID: 6491304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-C1q antibodies as a diagnostic marker of proliferative lupus nephritis: comment on the article by Katsumata et al.
    Trendelenburg M
    Arthritis Rheum; 2012 Jan; 64(1):324-5; author reply 325-6. PubMed ID: 21971910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlation of Thyroid Autoantibodies,System Lupus Erythematosus Immunologic Indicators and Disease Activity in SLE with HT].
    Liu H; Yang LH; Yin G; Xie QB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):179-182. PubMed ID: 29737056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
    Seelen MA; Trouw LA; Daha MR
    Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.
    Birmingham DJ; Bitter JE; Ndukwe EG; Dials S; Gullo TR; Conroy S; Nagaraja HN; Rovin BH; Hebert LA
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):47-53. PubMed ID: 26700439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example].
    Trendelenburg M; Schifferli JA
    Praxis (Bern 1994); 1998 Dec; 87(51-52):1811-3. PubMed ID: 10025155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
    Qi S; Chen Q; Xu D; Xie N; Dai Y
    Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement and systemic lupus erythematosus.
    Walport MJ
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S279-93. PubMed ID: 12110148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.